Search
News
Roswell Park Reports Positive Outcomes from New Combination Treatment for Ovarian Cancer
… response while preserving quality of life, notes Emese Zsiros, MD, PhD, FACOG , a staff physician and faculty member … the T cells often can’t get to the tumor,” says Dr. Zsiros, first author on the new paper. “We combined … took part in this clinical trial was excellent,” says Dr. Zsiros. “Most of them were able to travel, spend good time …
News
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
… which grew out of a phase 2 clinical trial led by Emese Zsiros, MD, PhD, FACOG , Chair and Director of Research, … can quickly age a patient’s immune system,” explains Dr. Zsiros, a gynecologic oncologist and senior author on the new … due to the weakened state of patients’ immune systems. Dr. Zsiros and team hypothesized that the varied responses …
News
Mapping of Ovarian Cancer Tumor Cell Microenvironment Highlights Key Role of T Cells
… at the University of Pennsylvania and led in part by Emese Zsiros, MD, PhD, FACOG , a Penn fellow at the time the … slows down tumor progression and recurrence,” said Dr. Zsiros. “The trafficking of T cells and other immune cells is … at the University of Pennsylvania and led in part by Emese Zsiros, MD, PhD, FACOG , a Penn fellow at the time the …
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
… recovery. How would patients fare without opioids? Emese Zsiros, MD, PhD, FACOG, a gynecologic oncologist at Roswell … based on their clinical experience. The results? Dr. Zsiros says the number of opioids prescribed to these … in the fight against the ongoing opioid epidemic.” Dr. Zsiros and her team reported the results from the first six …
Cancer Types
Recurrent Ovarian Cancer
News
Roswell Park Faculty Members Offer Expert Commentary on Immunotherapy Research
… Oncology . Co-authors for the commentary are Emese Zsiros, MD, PhD , Department of Gynecologic Oncology and … Oncology . Co-authors for the commentary are Emese Zsiros, MD, PhD , Department of Gynecologic Oncology and …
News
A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021
… Removing Unneeded Opioids From Our Communities Dr. Emese Zsiros Many patients are routinely sent home from the … to the threat of criminal activity? In 2018, Emese Zsiros, MD, PhD, FACOG , Assistant Professor of Oncology with … protocols. Read more about the work that Dr. Zsiros will be building on. 7. Mitigating Metastasis: …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne … George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne … George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne …
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
… MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS I Zsiros, Emese This is an open-label, phase 1, dose escalation …